Dose-ranging, randomized, clinical trial of atazanavir with lamivudine and stavudine in antiretroviral-naive subjects-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Dose-ranging, randomized, clinical trial of atazanavir with lamivudine and stavudine in antiretroviral-naive subjects

Published:2003-12 Issue:18 Volume:17 Page:2603-2614
ISSN:0269-9370
Container-title:AIDS
language:en
Short-container-title:AIDS

Author:

Murphy Robert L,Sanne Ian,Cahn Pedro,Phanuphak Praphan,Percival Lisa,Kelleher Thomas,Giordano Michael

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Infectious Diseases,Immunology,Immunology and Allergy

Reference34 articles.

1. A Randomized, Double-blind Trial Comparing Combinations of Nevirapine, Didanosine, and Zidovudine for HIV-Infected Patients

2. Lipid Abnormalities During Saquinavir Soft-Gel–Based Highly Active Antiretroviral Therapy

3. Effect of ritonavir on lipids and post-heparin lipase activities in normal subjects

4. Hyperlipidemia and Insulin Resistance Are Induced by Protease Inhibitors Independent of Changes in Body Composition in Patients With HIV Infection

5. Abnormal fat distribution and use of protease inhibitors

Cited by 166 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Natural products and synthetic analogues against HIV: A perspective to develop new potential anti-HIV drugs;European Journal of Medicinal Chemistry;2022-04

2. Apples to Apples? A Comparison of Real-World Tolerability of Antiretrovirals in Patients with Human Immunodeficiency Virus Infection and Patients with Primary Biliary Cholangitis;Viruses;2022-03-03

3. Dyslipidaemia after switch to tenofovir alafenamide (TAF)‐based cART regimens in a cohort of HIV‐positive patients: what clinical relevance?;HIV Medicine;2020-10-21

4. Protease Inhibitors for the Treatment of HIV/AIDS: Recent Advances and Future Challenges;Current Topics in Medicinal Chemistry;2019-10-09

5. Characteristics, Prevention, and Management of Cardiovascular Disease in People Living With HIV: A Scientific Statement From the American Heart Association;Circulation;2019-07-09

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3